Your browser doesn't support javascript.
loading
Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease.
Pavek, Adriene; Nartker, Christopher; Saleh, Maamoon; Kirkham, Matthew; Khajeh Pour, Sana; Aghazadeh-Habashi, Ali; Barrott, Jared J.
Afiliação
  • Pavek A; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
  • Nartker C; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
  • Saleh M; Whitman College, Walla Walla, WA 99362, USA.
  • Kirkham M; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
  • Khajeh Pour S; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
  • Aghazadeh-Habashi A; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
  • Barrott JJ; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
Biomedicines ; 9(5)2021 May 14.
Article em En | MEDLINE | ID: mdl-34068971
ABSTRACT
The applications of 3D bioprinting are becoming more commonplace. Since the advent of tissue engineering, bone has received much attention for the ability to engineer normal bone for tissue engraftment or replacement. While there are still debates on what materials comprise the most durable and natural replacement of normal tissue, little attention is given to recreating diseased states within the bone. With a better understanding of the cellular pathophysiology associated with the more common bone diseases, these diseases can be scaled down to a more throughput way to test therapies that can reverse the cellular pathophysiology. In this review, we will discuss the potential of 3D bioprinting of bone tissue in the following disease states osteoporosis, Paget's disease, heterotopic ossification, osteosarcoma, osteogenesis imperfecta, and rickets disease. The development of these 3D bioprinted models will allow for the advancement of novel therapy testing resulting in possible relief to these chronic diseases.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos